News from oncobiologics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 16, 2014, 09:00 ET

Strides Arcolab makes strategic investment in Oncobiologics, Inc., USA

Strides Arcolab and Oncobiologics, Inc., today announced that Strides has made a series of strategic investments in Oncobiologics, Inc., a...

Jun 26, 2014, 09:30 ET

Liomont and Oncobiologics partner to launch Biosimilars in Mexico

CRANBURY, N.J., June 26, 2014 /PRNewswire/ -- Oncobiologics, Inc. and Laboratorios Liomont S.A. de C.V. announced today a strategic...

Jun 12, 2014, 09:30 ET

Oncobiologics launches Phase I Clinical Trial for ONS-3010 Biosimilar version of Humira®

 Oncobiologics, Inc. announced today that it has received approval to initiate a Phase I clinical trial in Europe for its first biosimilar...

Jun 02, 2014, 09:00 ET

Ipca and Oncobiologics Create Strategic Biosimilars Partnership

Ipca Laboratories Ltd., India (Ipca) and Oncobiologics, Inc., USA (Oncobiologics) announced today the creation of a two-part...

Aug 06, 2013, 10:00 ET

Oncobiologics and inVentiv Health Form Strategic Partnership around Biosimilars

 Oncobiologics, Inc. and inVentiv Health today announced a broad strategic partnership around clinical development for all assets in...

May 08, 2013, 09:00 ET

Huahai and Oncobiologics Create Broad Biosimilars Partnership

 Oncobiologics, Inc. announced today that Zhejiang Huahai Pharmaceutical Co., Ltd and Oncobiologics have signed an alliance agreement for the...

Feb 25, 2013, 09:41 ET

Viropro and Oncobiologics Sign Emerging Markets Biosimilars Deal

 Viropro, Inc. (OTC: VPRO) and Oncobiologics, Inc. announced today the signing of a biosimilar collaboration agreement.  Under the...

Nov 06, 2012, 08:35 ET

Oncobiologics and Boston Oncology Team Up to Deliver Biosimilar Therapies for Cancer and Immune Disease to Middle East and North African Markets

 Oncobiologics, Inc. and Boston Oncology, LLC today announced a strategic partnership that will allow Boston Oncology to license, manufacture,...

Jul 30, 2012, 10:00 ET

Oncobiologics, Inc. Announces a Collaboration Agreement with XOMA Corporation to Utilize XOMA's Fully Human Antibody Libraries for Their Discovery Platform

Oncobiologics, Inc. announced today a collaboration agreement with XOMA Corporation to develop novel biotherapeutics based on engineering...

May 25, 2012, 07:50 ET

Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board

 Oncobiologics, Inc. announced today that it has filled two important leadership positions with established biopharmaceutical industry experts....

Oct 17, 2011, 10:00 ET
Pictured at the grand opening ribbon cutting event are (from left): Alfred Titone, U.S. Small Business Administration, New Jersey District Director; Pankaj Mohan, Ph.D., Oncobiologics, Founder & CEO; Lt. Gov. Kim Guadagno; Debbie Hart, BioNJ President; Sen. Robert Menendez; and Jeremy Caudill, Oncobiologics, Vice President Business Development.  (PRNewsFoto/Oncobiologics, Inc., Lauren Rutten)

Senator Menendez, Lt. Governor Guadagno Unveil New Biotech Firm Oncobiologics

Sen. Robert Menendez (D-NJ), Lt. Gov. Kim Guadagno and regional leaders of the biopharmaceutical industry Friday unveiled the state-of-the-art...

Oct 13, 2011, 10:00 ET

Oncobiologics, Inc. Announces Two New Agreements Worth Close to $80 Million

Oncobiologics announced today that it has signed two major agreements. The first is with Parilis Biopharmaceuticals, an early-stage biotech...

Oct 12, 2011, 10:31 ET

Oncobiologics Appoints Scott Canute, Former President of Eli Lilly and Genzyme, to its Board of Directors

Oncobiologics, Inc. announced today that is has named Scott Canute, a former President at both Eli Lilly and Genzyme, to its Board of Directors....

Aug 22, 2011, 12:10 ET

Oncobiologics, Inc. and Fox Chase Cancer Center Announce Co-Development of a Novel Cancer Therapy Platform

Oncobiologics, Inc. and Fox Chase Cancer Center announced today an agreement to co-develop a novel, next-generation bi-specific antibody cancer...

Jun 22, 2011, 07:35 ET

Oncobiologics, Inc. to Unveil New Biologics Proof-of-Concept Engine at BIO International Convention

The founders of Oncobiologics, Inc. today announced that the firm, a specialist in biologics proof-of-concept services, will launch itself to the...

Jun 21, 2011, 08:07 ET

Oncobiologics, Inc. to Unveil New Biologics Proof-of-Concept Engine at BIO International Convention

The founders of Oncobiologics, Inc. today announced that the firm, a specialist in biologics proof-of-concept services, will launch itself to the...